相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Bevacizumab in the Treatment of Ovarian Cancer
Florian Heitz et al.
ADVANCES IN THERAPY (2012)
Clinicopathologic and biological analysis of PIK3CA mutation in ovarian clear cell carcinoma
Munmun Rahman et al.
HUMAN PATHOLOGY (2012)
Navitoclax (ABT-263) Reduces Bcl-xL-Mediated Chemoresistance in Ovarian Cancer Models
Maureen Wong et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Drug development to overcome resistance to EGFR inhibitors in lung and colorectal cancer
Rodrigo Dienstmann et al.
MOLECULAR ONCOLOGY (2012)
Patient-derived tumour xenografts as models for oncology drug development
John J. Tentler et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
An integrated genomic approach identifies ARID1A as a candidate tumor-suppressor gene in breast cancer
A. Mamo et al.
ONCOGENE (2012)
Convergent structural alterations define SWItch/Sucrose NonFermentable (SWI/SNF) chromatin remodeler as a central tumor suppressive complex in pancreatic cancer
A. Hunter Shain et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Immunohistochemical expression of VEGF predicts response to platinum based chemotherapy in patients with epithelial ovarian cancer
G. K. Siddiqui et al.
ANGIOGENESIS (2011)
ARID1A, a Factor That Promotes Formation of SWI/SNF-Mediated Chromatin Remodeling, Is a Tumor Suppressor in Gynecologic Cancers
Bin Guan et al.
CANCER RESEARCH (2011)
IL6-STAT3-HIF Signaling and Therapeutic Response to the Angiogenesis Inhibitor Sunitinib in Ovarian Clear Cell Cancer
Michael S. Anglesio et al.
CLINICAL CANCER RESEARCH (2011)
Genomic Analysis Reveals the Molecular Heterogeneity of Ovarian Clear Cell Carcinomas
David S. P. Tan et al.
CLINICAL CANCER RESEARCH (2011)
Clear cell carcinoma of the ovary: A report from the first Ovarian Clear Cell Symposium, June 24th, 2010
Michael S. Anglesio et al.
GYNECOLOGIC ONCOLOGY (2011)
Ovarian cancer linked to lynch syndrome typically presents as early-onset, non-serous epithelial tumors
Zohreh Ketabi et al.
GYNECOLOGIC ONCOLOGY (2011)
Class III β-tubulin expression in advanced-stage serous ovarian carcinoma effusions is associated with poor survival and primary chemoresistance
Thea Eline Hetland et al.
HUMAN PATHOLOGY (2011)
Phase I Study of Navitoclax (ABT-263), a Novel Bcl-2 Family Inhibitor, in Patients With Small-Cell Lung Cancer and Other Solid Tumors
Leena Gandhi et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
First-in-Man Clinical Trial of the Oral Pan-AKT Inhibitor MK-2206 in Patients With Advanced Solid Tumors
Timothy A. Yap et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
PIK3CA mutation is an early event in the development of endometriosis-associated ovarian clear cell adenocarcinoma
Sohei Yamamoto et al.
JOURNAL OF PATHOLOGY (2011)
Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder
Yaoting Gui et al.
NATURE GENETICS (2011)
Identification of Novel Therapeutic Targets in Microdissected Clear Cell Ovarian Cancers
Michael P. Stany et al.
PLOS ONE (2011)
SWI/SNF nucleosome remodellers and cancer
Boris G. Wilson et al.
NATURE REVIEWS CANCER (2011)
The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
Robert J. Kurman et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
Tumor type and substage predict survival in stage I and II ovarian carcinoma: Insights and implications
Martin Koebel et al.
GYNECOLOGIC ONCOLOGY (2010)
Prognostic Relevance of Uncommon Ovarian Histology in Women With Stage III/IV Epithelial Ovarian Cancer
Helen J. Mackay et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2010)
Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
Ashour Ahmed Ahmed et al.
JOURNAL OF PATHOLOGY (2010)
Vascular Endothelial Growth Factor Is a Promising Therapeutic Target for the Treatment of Clear Cell Carcinoma of the Ovary
Seiji Mabuchi et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Researchers find a new cancer gene and a possible link between ovarian cancer and endometriosis
[Anonymous]
WOMENS HEALTH (2010)
Identification of an ovarian clear cell carcinoma gene signature that reflects inherent disease biology and the carcinogenic processes
K. Yamaguchi et al.
ONCOGENE (2010)
Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
Sian Jones et al.
SCIENCE (2010)
PTEN Deficiency in Endometrioid Endometrial Adenocarcinomas Predicts Sensitivity to PARP Inhibitors
Konstantin J. Dedes et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
A Current Review of Targeted Therapeutics for Ovarian Cancer
Susana M. Campos et al.
JOURNAL OF ONCOLOGY (2010)
Precursor Lesions of High-Grade Serous Ovarian Carcinoma: Morphological and Molecular Characteristics
Amy L. Gross et al.
JOURNAL OF ONCOLOGY (2010)
ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas
Kimberly C. Wiegand et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Frequent Activating Mutations of PIK3CA in Ovarian Clear Cell Carcinoma
Kuan-Ting Kuo et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
mTOR Is a Promising Therapeutic Target Both in Cisplatin-Sensitive and Cisplatin-Resistant Clear Cell Carcinoma of the Ovary
Seiji Mabuchi et al.
CLINICAL CANCER RESEARCH (2009)
PPM1D Is a Potential Therapeutic Target in Ovarian Clear Cell Carcinomas
David S. P. Tan et al.
CLINICAL CANCER RESEARCH (2009)
Methotrexate induces oxidative DNA damage and is selectively lethal to tumour cells with defects in the DNA mismatch repair gene MSH2
Sarah A. Martin et al.
EMBO MOLECULAR MEDICINE (2009)
The SWI/SNF complex and cancer
D. Reisman et al.
ONCOGENE (2009)
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
Jeffrey A. Engelman
NATURE REVIEWS CANCER (2009)
A Limited Panel of Immunomarkers Can Reliably Distinguish Between Clear Cell and High-grade Serous Carcinoma of the Ovary
Martin Köbel et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
The type 2C phosphatase Wip1: An oncogenic regulator of tumor suppressor and DNA damage response pathways
Xiongbin Lu et al.
CANCER AND METASTASIS REVIEWS (2008)
Protein phosphatase 2A (PP2A), a drugable tumor suppressor in Ph1(+) leukemias
Danilo Perrotti et al.
CANCER AND METASTASIS REVIEWS (2008)
Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma
Hiroaki Itamochi et al.
CANCER SCIENCE (2008)
Systematic Review and Meta-analysis of Ovarian Cancers: Estimation of Microsatellite-High Frequency and Characterization of Mismatch Repair Deficient Tumor Histology
Tuya Pal et al.
CLINICAL CANCER RESEARCH (2008)
Contents of endometriotic cysts, especially the high concentration of free iron, are a possible cause of carcinogenesis in the cysts through the iron-induced persistent oxidative stress
Ken Yamaguchi et al.
CLINICAL CANCER RESEARCH (2008)
Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers
John K. Chan et al.
GYNECOLOGIC ONCOLOGY (2008)
Low response rate of second-line chemotherapy for recurrent or refractory clear cell carcinoma of the ovary: a retrospective Japan Clear Cell Carcinoma Study
M. Takano et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2008)
ES cell pluripotency and germ-layer formation require the SWI/SNF chromatin remodeling component BAF250a
Xiaolin Gao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
My approach to and thoughts on the typing of ovarian carcinomas
W. G. McCluggage
JOURNAL OF CLINICAL PATHOLOGY (2008)
Ovarian clear cell adenocarcinoma: a continuing enigma
David S. P. Tan et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
A candidate precursor to serous carcinoma that originates in the distal fallopian tube
Y. Lee et al.
JOURNAL OF PATHOLOGY (2007)
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Richard M. Neve et al.
CANCER CELL (2006)
Wip1 phosphatase modulates ATM-dependent signaling pathways
Sathyavageeswaran Shreeram et al.
MOLECULAR CELL (2006)
Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase
H. Fujimoto et al.
CELL DEATH AND DIFFERENTIATION (2006)
PTEN expression in clear cell adenocarcinoma of the ovary
Y Hashiguchi et al.
GYNECOLOGIC ONCOLOGY (2006)
Expression of hepatocyte nuclear factor-1beta (HNF-1beta) in clear cell tumors and endometriosis of the ovary
N Kato et al.
MODERN PATHOLOGY (2006)
Unique gene expression profile based on pathologic response in epithelial ovarian cancer
D Spentzos et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The p270 (ARID1A/SMARCF1) subunit of mammalian SWI/SNF-related complexes is essential for normal cell cycle arrest
NG Nagl et al.
CANCER RESEARCH (2005)
Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer
KK Zorn et al.
CLINICAL CANCER RESEARCH (2005)
Clear-cell cancer of the ovary - is it chemosensitive?
S Pather et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2005)
Epigenetic inactivation of TMS1/ASC in ovarian cancer
K Terasawa et al.
CLINICAL CANCER RESEARCH (2004)
Cellular and molecular studies on cisplatin-induced apoptotic cell death in rat kidney
D Sheikh-Hamad et al.
ARCHIVES OF TOXICOLOGY (2004)
Characterization of intraperitoneal, orthotopic, and metastatic xenograft models of human ovarian cancer
TJ Shaw et al.
MOLECULAR THERAPY (2004)
Microsatellite instability and alteration of the expression of hMLH1 and hMSH2 in ovarian clear cell carcinoma
KQ Cai et al.
HUMAN PATHOLOGY (2004)
Evaluation of monoclonal humanized anti-HER2 antibody, trastuzumab, in patients with recurrent or refractory ovarian or primary peritoneal carcinoma with overexpression of HER2: A phase II trial of the Gynecologic Oncology Group
MA Bookman et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
HER2 is frequently over-expressed in ovarian clear cell adenocarcinoma: Possible novel treatment modality using recombinant monoclonal antibody against HER2, trastuzumab
M Fujimura et al.
JAPANESE JOURNAL OF CANCER RESEARCH (2002)
p53-inducible Wip1 phosphatase mediates a negative feedback regulation of p38 MAPK-p53 signaling in response to UV radiation
M Takekawa et al.
EMBO JOURNAL (2000)
Genetic aberrations detected by comparative genomic hybridization in ovarian clear cell adenocarcinomas
Y Suehiro et al.
ONCOLOGY (2000)
分享论文
